Based on the importance of tumor MHC-I expression and intact IFNγ signaling for clinical response to single agent anti-PD1 immunotherapy [13,14,26], we designed a rational workflow to generate a transplantable mouse melanoma model responsive to PD1 blockade. This evidence concerns the gene PDCD1 and neoplasm.